We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.82%
2 Technology 2.79%
3 Financials 2.26%
4 Consumer Discretionary 1.92%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAJ
14551
CALL
DELISTED
Canon, Inc.
CAJ
-9,700
Closed -$236K
EBACW
14552
DELISTED
European Biotech Acquisition Corp. Warrant
EBACW
-303,681
Closed -$61K
EBAC
14553
DELISTED
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
-625,916
Closed -$6.1M
ANAC.WS
14554
DELISTED
Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ANAC.WS
-150,100
Closed -$52K
ATNX
14555
PUT
DELISTED
Athenex, Inc. Common Stock
ATNX
-1,880
Closed -$31K
MTCR
14556
DELISTED
Metacrine, Inc. Common Stock
MTCR
-41,144
Closed -$19.9K
LCI
14557
DELISTED
Lannett Company, Inc.
LCI
-11,672
Closed -$29K
KSCD
14558
DELISTED
KFA Small Cap Quality Dividend Index ETF
KSCD
-46,175
Closed -$1.31M
VIVO
14559
DELISTED
Meridian Bioscience Inc
VIVO
-45,651
Closed -$1.23M
SVFA
14560
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
-17,250
Closed -$170K
BNFT
14561
PUT
DELISTED
Benefitfocus, Inc.
BNFT
-11,800
Closed -$149K
MMX
14562
CALL
DELISTED
Maverix Metals Inc. Common Shares
MMX
-14,200
Closed -$68K
MMX
14563
DELISTED
Maverix Metals Inc. Common Shares
MMX
-157,617
Closed -$717K
EPHYW
14564
DELISTED
Epiphany Technology Acquisition Corp. Warrant
EPHYW
-225,185
Closed -$76K
EPHY
14565
CALL
DELISTED
Epiphany Technology Acquisition Corp. Class A Common Stock
EPHY
-38,600
Closed -$379K
USER
14566
DELISTED
UserTesting, Inc.
USER
-46,586
Closed -$498K
POWRU
14567
DELISTED
Powered Brands Units
POWRU
-10,102
Closed -$100K
STAB
14568
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
-20,368
Closed -$5.27K
SHCA
14569
DELISTED
Spindletop Health Acquisition Corp. Class A Common Stock
SHCA
-750,179
Closed -$7.54M
HIL
14570
CALL
DELISTED
Hill International, Inc. Common Stock
HIL
-23,300
Closed -$38K
FPAC.WS
14571
DELISTED
Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
FPAC.WS
-411,120
Closed -$670K
HCIC
14572
DELISTED
Hennessy Capital Investment Corp. V Class A Common Stock
HCIC
-27,063
Closed -$266K
GNACW
14573
DELISTED
Group Nine Acquisition Corp. Warrant
GNACW
-133,333
Closed -$35K
HCIIW
14574
DELISTED
Hudson Executive Investment Corp. II Warrant
HCIIW
-89,238
Closed -$34K
SCOAW
14575
DELISTED
ScION Tech Growth I Warrant
SCOAW
-753,668
Closed -$203K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.